
DarioHealth (DRIO) Stock Forecast & Price Target
DarioHealth (DRIO) Analyst Ratings
Bulls say
DarioHealth is well-positioned for success in the growing digital health market, with a unique vertically integrated platform and strong focus on customer engagement and clinical outcomes. Despite recent challenges in their B2B2C and strategic partnerships channels, the company has improved its pipeline and commercial progress, leading to optimism for future revenue growth and potential EBITDA breakeven by 2026/2027. However, risks associated with the HCIT space and potential challenges in achieving customer retention and capturing sufficient lives may impact the company's future success.
Bears say
DarioHealth is a virtual chronic care company that provides personalized digital and human coaching on chronic conditions and owns a complete chain of value in chronic care management. However, there are potential risks associated with the healthcare IT (HCIT) space, including constrained hospital budgets and customer losses due to facility consolidation, which could hinder DarioHealth's growth potential. Additionally, the company's focus on B2B2C solutions and the need for continuous cash flow may lead to dilutive capital raises, limiting its cash runway.
This aggregate rating is based on analysts' research of DarioHealth and is not a guaranteed prediction by Public.com or investment advice.
DarioHealth (DRIO) Analyst Forecast & Price Prediction
Start investing in DarioHealth (DRIO)
Order type
Buy in
Order amount
Est. shares
0 shares